Voyager Therapeutics shareholders approve authorized share increase at annual meeting

• Voyager held its 2026 annual shareholder meeting on June 9, 2026.
• Shareholders backed a charter amendment to lift authorized capital stock to 245 million shares from 125 million.
• The same amendment raised authorized common stock to 240 million shares from 120 million.
• The charter amendment was executed through a certificate of amendment filed on June 9, 2026, effective upon filing.
• Shareholders ratified Ernst & Young as independent auditor for the fiscal year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyager Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-072324), on June 10, 2026, and is solely responsible for the information contained therein.